Reaction

Lung Transplant reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,519 reports · 59 co-occurring drugs

As of the last recalculation, Lung Transplant appears in 3,519 FAERS reports alongside 59 co-occurring drug terms. The strongest observed disproportionality signal is EPOPROSTENOL (PRR 122.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Epoprostenol	252	122.6	125.0
Nintedanib	234	47.2	47.6
Bosentan	347	45.1	45.4
Macitentan	453	44.3	44.6
Lumacaftor And Ivacaftor	63	44.3	44.6
Sildenafil Powder,	218	38.6	38.8
Dornase Alfa	118	36.8	37.0
Sildenafil	318	35.6	35.8
Ambrisentan	618	35.3	35.5
Ivacaftor	42	31.6	31.8
Tobramycin Solution	56	28.0	28.1
Riociguat	148	28.0	28.1
Tobramycin Sulfate	57	27.7	27.8
Tobramycin	102	25.8	25.9
Sildenafil Citrate	463	24.6	24.7
Selexipag	100	23.5	23.6
Elexacaftor, Tezacaftor, And Ivacaftor	45	21.6	21.7
Treprostinil	403	21.3	21.4
Tadalafil	308	19.8	19.9
Pancrelipase	101	15.9	15.9
0Xygen	127	15.8	15.8
Oxygen	127	15.8	15.8
Pirfenidone	102	15.2	15.3
Valganciclovir Hydrochloride Powder,	31	15.2	15.2
Valganciclovir	47	14.9	15.0
Valganciclovir Hydrochloride	47	14.9	15.0
Amikacin	33	11.5	11.6
Atovaquone	14	10.3	10.3
Ursosiol	27	8.3	8.3
Itraconazole	16	8.1	8.1
Ursodiol	27	7.4	7.4
Voriconazole Injection	23	6.3	6.3
Voriconazole	32	6.3	6.3
Posaconazole	17	6.2	6.2
Mycophenilic Acid	20	5.7	5.7
Bumetanide	25	5.6	5.6
Mycophenolic Acid	30	5.6	5.6
Sodium Chloride Tablet	67	5.5	5.5
Sodium Chloride Tablets	67	5.5	5.5
Azithromycin Dihydrate	53	5.4	5.4
Posaconazole Delayed-Release	10	5.4	5.4
Azithromycin	36	5.3	5.3
Azithromycin Monohydrate	36	5.2	5.2
Sodium Chloride	67	5.1	5.1
Micafungin Sodium	7	4.9	4.9
Tacrolimus	123	4.8	4.8
Fluticasone Propionate And Salmeterol Xinafoate	47	4.7	4.7
Basiliximab	9	4.5	4.5
Alendronate Sodium Tablet	14	4.5	4.5
Warfarin	93	4.4	4.4
Dronabinol	6	4.4	4.4
Benzonatate	12	4.3	4.3
Tacrolimus Ointment 0.1%	85	4.1	4.1
Tacrolimus Extended-Release Capsules	85	4.1	4.1
Iohexol	4	2.9	2.9
Mepolizumab	23	2.7	2.8
Daptomycin	4	2.6	2.6
Benralizumab	6	1.8	1.8
Glecaprevir And Pibrentasvir	3	1.6	1.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.